Healios KK Ord Shs HLOSF

Healthcare Biotechnology

HEALIOS K.K. is a Japan-based company mainly engaged in research and development of pharmaceutical products. The Company has compound pharmaceutical products line and induced pluripotent stem cell (iPSC) regenerative medicine product line. The compound pharmaceutical product line contains HLM0021, HLM0022 and HLM0023. The products are ophthalmological surgery adjuvants, mainly contain brilliant blue G-250 (BBG250) which help capsule temporarily safely stained to protect the inner limiting membranes and lens during surgery of vitreous and cataract. The iPSC regenerative medicine product line contains HLCR011 and HLCR012. The products are in the preclinical testing and preparation for trial in Japan, which are candidate of regenerative medicine products. The products are iPS cell derived retinal pigment epithelium (RPE) cell suspension and sheet developed in Japan, United States and Europe.

PINL:HLOSF - Post by User

Healios KK Ord Shs > Depth

<< Previous

Bullboard Posts

Next >>

Comment by waynedon Jul 15, 2011 5:18pm

230 Views

Post# 18837373

RE: Depth

They won`t answer any e-mails so I sent them a very nasty one. Nobody will read it anyway but it makes me feel better. Hard to believe they could screw this up , although they are taking out big wages for no apparent effort. You get two or three companies like that and you make a very nice living with lots of spare time .

<< Previous

Bullboard Posts

Next >>

Silvercorp to expand into Ecuador with C$200M Adventus acquisition